Search research articles
Contact Us
Filters
Showing results (1-10 of 96) with videos related to
Page
of 10
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
May 28, 2019
Multiple Myeloma: Current Advances and Future Directions
Thomas Martin, Carol Ann Huff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2008
Multiple myeloma cancer stem cells
Carol Ann Huff, William Matsui
Current Opinion in Oncology
|
March 7, 2002
Bone marrow transplantation for multiple myeloma: where we are today
Carol Ann Huff, Richard J Jones
Journal of Oncology Practice
|
August 16, 2018
Multiprofessional Ward Rounds for Inpatients With Advanced Cancers: Too Big to Succeed?
William G Nelson, Peter J Pronovost, Carol Ann Huff
Cell Cycle (Georgetown, Tex.)
|
March 19, 2015
IBRUTinib: BRUTe force against bortezomib-resistant myeloma cells
Lingling Xian, Carol Ann Huff, Linda M S Resar
Blood
|
September 10, 2005
The paradox of response and survival in cancer therapeutics
Carol Ann Huff, William Matsui, B Douglas Smith, et al.
British Journal of Haematology
|
January 19, 2011
Bortezomib and thalidomide, a steroid free regimen in newly diagnosed patients with multiple myeloma
Nilanjan Ghosh, Xiaobu Ye, Anna Ferguson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 29, 2006
Strategies to eliminate cancer stem cells: clinical implications
Carol Ann Huff, William H Matsui, B Douglas Smith, et al.
American Journal of Hematology
|
April 12, 2014
Clarithromycin overcomes resistance to lenalidomide and dexamethasone in multiple myeloma
Nilanjan Ghosh, Noah Tucker, Marianna Zahurak, et al.
Journal of the Peripheral Nervous System : JPNS
|
October 19, 2011
Comment on research report by Gruson and colleagues, this issue
Carol Ann Huff, Ingemar S J Merkies, Richard A C Hughes, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 96) with videos related to
Sort By:
Page
of 10
Clinical Lymphoma, Myeloma & Leukemia
|
May 28, 2019
Multiple Myeloma: Current Advances and Future Directions
Thomas Martin, Carol Ann Huff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2008
Multiple myeloma cancer stem cells
Carol Ann Huff, William Matsui
Current Opinion in Oncology
|
March 7, 2002
Bone marrow transplantation for multiple myeloma: where we are today
Carol Ann Huff, Richard J Jones
Journal of Oncology Practice
|
August 16, 2018
Multiprofessional Ward Rounds for Inpatients With Advanced Cancers: Too Big to Succeed?
William G Nelson, Peter J Pronovost, Carol Ann Huff
Cell Cycle (Georgetown, Tex.)
|
March 19, 2015
IBRUTinib: BRUTe force against bortezomib-resistant myeloma cells
Lingling Xian, Carol Ann Huff, Linda M S Resar
Blood
|
September 10, 2005
The paradox of response and survival in cancer therapeutics
Carol Ann Huff, William Matsui, B Douglas Smith, et al.
British Journal of Haematology
|
January 19, 2011
Bortezomib and thalidomide, a steroid free regimen in newly diagnosed patients with multiple myeloma
Nilanjan Ghosh, Xiaobu Ye, Anna Ferguson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 29, 2006
Strategies to eliminate cancer stem cells: clinical implications
Carol Ann Huff, William H Matsui, B Douglas Smith, et al.
American Journal of Hematology
|
April 12, 2014
Clarithromycin overcomes resistance to lenalidomide and dexamethasone in multiple myeloma
Nilanjan Ghosh, Noah Tucker, Marianna Zahurak, et al.
Journal of the Peripheral Nervous System : JPNS
|
October 19, 2011
Comment on research report by Gruson and colleagues, this issue
Carol Ann Huff, Ingemar S J Merkies, Richard A C Hughes, et al.
Page
of 10